Argireline vs MOTS-c

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Argireline

Argireline (Acetyl Hexapeptide-3) is a widely-used cosmetic peptide that reduces wrinkle depth by inhibiting neurotransmitter release. One of the first 'Botox-like' peptides developed for topical use.

Full details →

MOTS-c

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a mitochondrial-derived peptide that plays a key role in metabolic regulation and has emerged as a significant longevity research target.

Full details →

Side-by-Side Comparison

Aspect	Argireline	MOTS-c
Dose Range	500 mcg–1 mg	5 mg–10 mg
Frequency	2x daily	Less than daily
Cycle Length	4–8 weeks	8–12 weeks
Route	topical	subcutaneous
Mechanism	Inhibits the formation of the SNARE complex required for neurotransmitter release, reducing the intensity of muscle contractions that cause expression lines.	Activates AMPK pathway, enhances glucose uptake in skeletal muscle, improves insulin sensitivity, and regulates mitochondrial function. Acts as a metabolic hormone affecting whole-body energy homeostasis.
Typical Dosage	Topical: 5-10% concentration in serums, applied twice daily. Higher concentrations used in professional treatments.	Research protocols typically use 5-10mg administered subcutaneously several times per week. Optimal dosing not yet established.
Administration	Topical application to clean skin. Most effective on expression lines (forehead, crow's feet). Consistent use required for visible results.	Subcutaneous injection. Often combined with exercise protocols as it enhances exercise capacity and metabolic adaptation.
Side Effects	Generally very well-tolerated. Occasional mild irritation or dryness. No systemic absorption at cosmetic doses.	Limited human data. Animal studies show good tolerability. May affect energy levels and exercise performance.
Best For	Anti-Aging & Longevity Skin Health & Aesthetics	Muscle Growth Fat Loss Anti-Aging & Longevity